BMRN reports Monday, Feb 22, 2027, after the close. After the last 4 reports the stock moved −3.1%, +3.8%, −4.0%, −0.5% the next day.
BMRN is expected to report on Monday, Feb 22, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 2, 2026 | -0.11 | 0.23 | −3.1% | −0.5% |
| Aug 6, 2026 | 0.95 | 1.20 | +3.8% | +11.5% |
| May 4, 2026 | 0.91 | 0.76 | −4.0% | −5.2% |
| Feb 23, 2026 | 0.56 | 0.46 | −0.5% | −5.1% |
| Oct 27, 2025 | 0.34 | 0.12 | +1.6% | +0.3% |
| Aug 4, 2025 | 1.03 | 1.44 | +2.7% | −5.8% |
| May 1, 2025 | 0.95 | 1.13 | −1.1% | −4.6% |
| Feb 19, 2025 | 0.74 | 0.92 | +4.8% | +4.9% |
Average move the next trading day over the last 8 reports: ±2.7% (4 of 8 up).
BMRN is in an uptrend, momentum firm. $60.65 is the level overhead; $60 the first support below.
BMRN at $60.41. Nearest resistance $60.65 (+0.4%). Nearest support $60.00 (−0.7%).
BMRN chart, levels and analysis · Latest analysis: BioMarin Pharmaceutical (BMRN) stock analysis, November 20, 2026: bullish on short‑term upside · Earnings this week
BMRN is expected to report on Monday, Feb 22, 2027, after the close.
BMRN reports after the close, US Eastern time.
After its report on Nov 2, 2026, BMRN moved −3.1% the next trading day.
Over the last 8 reports, BMRN moved 2.7% on average the next trading day, up 4 times out of 8.
Updated Nov 3, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.